课题基金 / 基金详情

VACCINE AND TREATMENT EVALUATION UNIT: PHASE I EBOLA VACCINE TRIAL

VACCINE AND TREATMENT EVALUATION UNIT: PHASE I EBOLA VACCINE TRIAL
疫苗和治疗评估单位：第一阶段埃博拉疫苗试验
批准号：
10672156
负责人：
ROBERT FRENCK
金额：
$10.3万
依托单位：
CINCINNATI CHILDRENS HOSP MED CTR
依托单位国家：
美国
项目类别：
财政年份：
2017
资助国家：
美国
项目状态：
已结题
起止时间：
2017-08-28 至 2023-07-31
来源：
https://reporter.nih.gov/project-details/10672156
关键词：
Communicable DiseasesConduct Clinical TrialsContractsEbola VaccinesEbola virusEvaluationIndividualPhasePhase I Clinical TrialsPopulationResourcesSpecial PopulationVaccinescombatdesignprogramsvaccine candidatevaccine trial

项目摘要

项目成果

ROBERT FRENCK的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This program is comprised of a consortium of individual contracts within academic centers and organizations that provide a ready resource for the design and conduct of clinical trials to evaluate promising products to combat infectious diseases. In general, products will be evaluated in normal healthy populations; however, access to special populations is also available.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Vaccine and Treatment Evaluation Units: Overall Administration, Clinical Operations Support, Protocol Development, Implementation and Assays
Vaccine and Treatment Evaluation Units: Protocol Development and Implementation of a Natural History Challenge Study for Influenza
Vaccine and Treatment Evaluation Units: Overall Administration, Clinical Operations Support, Protocol Development, Implementation and Assays
Vaccine and Treatment Evaluation Units: Clinical Trial for a Shigella Vaccine Candidate
海外基金